NICOLE MCBRYDE: Open Payments
NPI 1275033839 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 18 payments from 9 companies in 2025. Trend: 2023 $644 · 2024 $477 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $87 |
| Phathom Pharmaceuticals, Inc. | 5 | $57 |
| Janssen Biotech, Inc. | 3 | $51 |
| Celltrion USA Inc. | 2 | $34 |
| GENZYME CORPORATION | 1 | $26 |
| ABBVIE INC. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Ardelyx, Inc. | 1 | $16 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
Products named: VOQUEZNA, ENTYVIO, TREMFYA, VEGZELMA, GATTEX, DUPIXENT, MAVYRET, VELSIPITY.
Industry payments across TX — which companies pay providers there.
